Apolipoprotein A5 ameliorates MCT induced pulmonary hypertension by inhibiting ER stress in a GRP78 dependent mechanism

Abstract Background Pulmonary arterial hypertension (PAH) is a chronic, progressive lung vascular disease accompanied by elevated pulmonary vascular pressure and resistance, and it is characterized by increased pulmonary artery smooth muscle cell (PASMC) proliferation. Apolipoprotein A5 (ApoA5) impr...

Full description

Bibliographic Details
Main Authors: Jingyuan Chen, Jun Luo, Haihua Qiu, Yi Tang, Xiaojie Yang, Yusi Chen, Zilu Li, Jiang Li
Format: Article
Language:English
Published: BMC 2022-08-01
Series:Lipids in Health and Disease
Subjects:
Online Access:https://doi.org/10.1186/s12944-022-01680-4
_version_ 1811320826924892160
author Jingyuan Chen
Jun Luo
Haihua Qiu
Yi Tang
Xiaojie Yang
Yusi Chen
Zilu Li
Jiang Li
author_facet Jingyuan Chen
Jun Luo
Haihua Qiu
Yi Tang
Xiaojie Yang
Yusi Chen
Zilu Li
Jiang Li
author_sort Jingyuan Chen
collection DOAJ
description Abstract Background Pulmonary arterial hypertension (PAH) is a chronic, progressive lung vascular disease accompanied by elevated pulmonary vascular pressure and resistance, and it is characterized by increased pulmonary artery smooth muscle cell (PASMC) proliferation. Apolipoprotein A5 (ApoA5) improves monocrotaline (MCT)-induced PAH and right heart failure; however, the underlying mechanism remains unknown. Here we speculate that ApoA5 has a protective effect in pulmonary vessels and aim to evaluate the mechanism. Methods ApoA5 is overexpressed in an MCT-induced PAH animal model and platelet-derived growth factor (PDGF)-BB-induced proliferating PASMCs. Lung vasculature remodeling was measured by immunostaining, and PASMC proliferation was determined by cell counting kit‐8 and 5‐ethynyl‐2'‐deoxyuridine5‐ethynyl‐2'‐deoxyuridine incorporation assays. Coimmunoprecipitation-mass spectrometry was used to investigate the probable mechanism. Next, its role and mechanism were further verified by knockdown studies. Results ApoA5 level was decreased in MCT-induced PAH lung as well as PASMCs. Overexpression of ApoA5 could help to inhibit the remodeling of pulmonary artery smooth muscle. ApoA5 could inhibit PDGF-BB-induced PASMC proliferation and endoplasmic reticulum stress by increasing the expression of glucose-regulated protein 78 (GRP78). After knocking down GRP78, the protecting effects of ApoA5 have been blocked. Conclusion ApoA5 ameliorates MCT-induced PAH by inhibiting endoplasmic reticulum stress in a GRP78 dependent mechanism.
first_indexed 2024-04-13T13:07:32Z
format Article
id doaj.art-7ff7967ffeb44d308a5db9e4244a1a7d
institution Directory Open Access Journal
issn 1476-511X
language English
last_indexed 2024-04-13T13:07:32Z
publishDate 2022-08-01
publisher BMC
record_format Article
series Lipids in Health and Disease
spelling doaj.art-7ff7967ffeb44d308a5db9e4244a1a7d2022-12-22T02:45:44ZengBMCLipids in Health and Disease1476-511X2022-08-0121111210.1186/s12944-022-01680-4Apolipoprotein A5 ameliorates MCT induced pulmonary hypertension by inhibiting ER stress in a GRP78 dependent mechanismJingyuan Chen0Jun Luo1Haihua Qiu2Yi Tang3Xiaojie Yang4Yusi Chen5Zilu Li6Jiang Li7Department of Cardiovascular Medicine, Second Xiangya Hospital of Central South UniversityDepartment of Cardiovascular Medicine, Second Xiangya Hospital of Central South UniversityDepartment of Cardiovascular Medicine, Second Xiangya Hospital of Central South UniversityDepartment of Cardiology, Clinical Medicine Research Center of Heart Failure of Hunan Province, Hunan Provincial People’s Hospital, The First Affiliated Hospital of Hunan Normal University, Hunan Normal UniversityDepartment of Cardiovascular Medicine, Second Xiangya Hospital of Central South UniversityDepartment of Cardiovascular Medicine, Second Xiangya Hospital of Central South UniversityDepartment of Cardiovascular Medicine, Second Xiangya Hospital of Central South UniversityDepartment of Cardiovascular Medicine, Second Xiangya Hospital of Central South UniversityAbstract Background Pulmonary arterial hypertension (PAH) is a chronic, progressive lung vascular disease accompanied by elevated pulmonary vascular pressure and resistance, and it is characterized by increased pulmonary artery smooth muscle cell (PASMC) proliferation. Apolipoprotein A5 (ApoA5) improves monocrotaline (MCT)-induced PAH and right heart failure; however, the underlying mechanism remains unknown. Here we speculate that ApoA5 has a protective effect in pulmonary vessels and aim to evaluate the mechanism. Methods ApoA5 is overexpressed in an MCT-induced PAH animal model and platelet-derived growth factor (PDGF)-BB-induced proliferating PASMCs. Lung vasculature remodeling was measured by immunostaining, and PASMC proliferation was determined by cell counting kit‐8 and 5‐ethynyl‐2'‐deoxyuridine5‐ethynyl‐2'‐deoxyuridine incorporation assays. Coimmunoprecipitation-mass spectrometry was used to investigate the probable mechanism. Next, its role and mechanism were further verified by knockdown studies. Results ApoA5 level was decreased in MCT-induced PAH lung as well as PASMCs. Overexpression of ApoA5 could help to inhibit the remodeling of pulmonary artery smooth muscle. ApoA5 could inhibit PDGF-BB-induced PASMC proliferation and endoplasmic reticulum stress by increasing the expression of glucose-regulated protein 78 (GRP78). After knocking down GRP78, the protecting effects of ApoA5 have been blocked. Conclusion ApoA5 ameliorates MCT-induced PAH by inhibiting endoplasmic reticulum stress in a GRP78 dependent mechanism.https://doi.org/10.1186/s12944-022-01680-4Pulmonary arterial hypertensionApolipoprotein A5Endoplasmic reticulum stressGlucose- regulated protein 78
spellingShingle Jingyuan Chen
Jun Luo
Haihua Qiu
Yi Tang
Xiaojie Yang
Yusi Chen
Zilu Li
Jiang Li
Apolipoprotein A5 ameliorates MCT induced pulmonary hypertension by inhibiting ER stress in a GRP78 dependent mechanism
Lipids in Health and Disease
Pulmonary arterial hypertension
Apolipoprotein A5
Endoplasmic reticulum stress
Glucose- regulated protein 78
title Apolipoprotein A5 ameliorates MCT induced pulmonary hypertension by inhibiting ER stress in a GRP78 dependent mechanism
title_full Apolipoprotein A5 ameliorates MCT induced pulmonary hypertension by inhibiting ER stress in a GRP78 dependent mechanism
title_fullStr Apolipoprotein A5 ameliorates MCT induced pulmonary hypertension by inhibiting ER stress in a GRP78 dependent mechanism
title_full_unstemmed Apolipoprotein A5 ameliorates MCT induced pulmonary hypertension by inhibiting ER stress in a GRP78 dependent mechanism
title_short Apolipoprotein A5 ameliorates MCT induced pulmonary hypertension by inhibiting ER stress in a GRP78 dependent mechanism
title_sort apolipoprotein a5 ameliorates mct induced pulmonary hypertension by inhibiting er stress in a grp78 dependent mechanism
topic Pulmonary arterial hypertension
Apolipoprotein A5
Endoplasmic reticulum stress
Glucose- regulated protein 78
url https://doi.org/10.1186/s12944-022-01680-4
work_keys_str_mv AT jingyuanchen apolipoproteina5amelioratesmctinducedpulmonaryhypertensionbyinhibitingerstressinagrp78dependentmechanism
AT junluo apolipoproteina5amelioratesmctinducedpulmonaryhypertensionbyinhibitingerstressinagrp78dependentmechanism
AT haihuaqiu apolipoproteina5amelioratesmctinducedpulmonaryhypertensionbyinhibitingerstressinagrp78dependentmechanism
AT yitang apolipoproteina5amelioratesmctinducedpulmonaryhypertensionbyinhibitingerstressinagrp78dependentmechanism
AT xiaojieyang apolipoproteina5amelioratesmctinducedpulmonaryhypertensionbyinhibitingerstressinagrp78dependentmechanism
AT yusichen apolipoproteina5amelioratesmctinducedpulmonaryhypertensionbyinhibitingerstressinagrp78dependentmechanism
AT ziluli apolipoproteina5amelioratesmctinducedpulmonaryhypertensionbyinhibitingerstressinagrp78dependentmechanism
AT jiangli apolipoproteina5amelioratesmctinducedpulmonaryhypertensionbyinhibitingerstressinagrp78dependentmechanism